Optimising HFO&VTV in Newborn Infants

Recruiting N/A Interventional Study
High Frequency Oscillation Volume Targeted Ventilation
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
22 Weeks – 1
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
27 (estimated)
Sponsor
King's College Hospital NHS Trust · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Mechanical ventilation (MV) is life saving for infants requiring respiratory support in the newborn period but its use has been associated with complications. High frequency oscillation (HFO) is a type of MV that delivers small volumes of gas across the lungs at fast frequencies. HFO is a lung protective strategy but it has also been linked to brain injury due to low carbon dioxide tensions. High-…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: -Newborn infants of any gestation receiving high frequency oscillatory ventilation Exclusion Criteria: * Infants with known intracerebral pathology (stroke, hydrocephalus, intracerebral hemorrhage, severe hypoxic ischemic encephalopathy). * Infants with congenital cardiac abno…
Contacts

Ourania Kaltsogianni, MSc

0044+02032999000

ourania.kaltsogianni@nhs.net

CONTACT

Theodore Dassios

theodore.dassios@nhs.net

CONTACT